Actavis

Compass Pathways Files for an IPO at NASDAQ UK-based Compass Pathways wants to become the first psychedelics company to list on a major U.S. stock exchange. The psilocybin research company intends to make its initial public offering (IPO) through NASDAQ under the ticker symbol...

U.K. company Reckitt Benckiser Group plc has delivered the largest M&A deal so far in 2017 by announcing a $19 billion buyout of U.S. company Mead Johnson Nutrition CO (NYSE: MJN). According to CNBC’s Carl Quintanilla, the Mead Johnson buyout is the fourth-largest foreign buyout of a U.S...

Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) reported better-than-expected results for its fourth quarter, driven by the acquisition of Actavis Generics business. The company also reaffirmed its 2017 outlook, which also came in above consensus expectations. Teva Q4 EPS $1.38 vs $1.35...

Bernstein said the departure of Siggi Olafsson is negative for Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA), as investors may fear the move is reflective of deeper malaise. ADRs of Teva were down 3.89 percent in Tuesday’s pre-market hours. Olafsson's Departure Teva announced that...

Oracle Corporation (NYSE: ORCL) announced a massive $14 billion corporate bond sale this week. The company plans on using the proceeds for stock repurchases, dividend payments, debt refinancing and other budget items. While certainly impressive, Oracle’s sale is not even one of the five...

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) has been in the news a lot lately. Among the potentially unsavory news is the surprise return of CEO Mike Pearson after an extended sick leave, a canceled conference call followed by one-on-one calls to certain bullish analysts, which then raised...

The news of generic challenger for Xifaxan 550mg is brought down the shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX). Though Valeant has adequate patent protection for the drug, the recent news added fuel to the negative investor sentiment on the stock, which has dropped 63 percent in the...

In a recent article published on Forbes, Data Journalist Niall McCarthy looks into patent disputes in the United States, concluding that the country is set to see a record number of patent disputes this year. According to a report issued by Unified Patents, projections suggest 2015 will witness...

Dublin based Actavis plc (NYSE: ACT) reported Q1 earnings on Monday, beating analyst estimates for revenue and adjusted earnings. GAAP net loss in the quarter exceeded $500 million due to non-recurring expenses. Acquisition integration and a shift toward branded drugs represent continued...

U.S. markets opened in negative territory to start the week following news reports that Japan's economy unexpectedly contracted in the third quarter. U.S. stocks rebounded after the European Central Bank's President Mario Draghi stating that the central bank remains "unanimous in...

U.S. stocks were little changed on Wednesday in another quiet trading session due to a lack of catalysts to move stocks. Economic data showed wholesale inventories rose more than expected in September. Looking forward to Thursday, retail giant Wal-Mart will report earnings before market open...

U.S. stocks were mostly higher after Republicans took control of the Senate after Tuesday's elections as the Dow Jones Industrial Average (INDEXDJX: .DJI) and S&P 500 (INDEXSP: .INX) both closed at historical all-time highs. "Congress will pass some bills I cannot sign; I'm...